Latest
finance.yahoo.com Earnings
Hengrui Pharma Reports 2026 Interim Results as Innovation and Globalization Continue to Drive Business Momentum
SHANGHAI, Aug. 19, 2026 /PRNewswire/ -- Hengrui Pharma ("Hengrui" or "the Company") today announced its financial results for the first half of 2026. During the reporting period, innovative drugs remained the Company's key growth driver, while globalization initiatives continued to validate the global value of Hengrui's innovation portfolio. Financial Highlights In the first half of 2026, Hengrui reported …
Main company
🇨🇳 China
Read at finance.yahoo.com